文献速递腹部技术与安全CTMR

影像组学在胰腺癌预后预测中的系统评价:异质性标志物还是统计学技巧?

A systematic review of prognosis predictive role of radiomics in pancreatic cancer: heterogeneity markers or statistical tricks?
PubMed 文献 · Eur Radiol · 2022-07-29

该系统评价纳入23项关于胰腺导管腺癌治疗前影像组学预测总生存期的研究,其中9项研究的一阶熵与总生存期显著相关(HR 1.66,95%CI 1.18-2.34);仅5项研究进行内部验证、2项进行外部验证,22项研究因回顾性设计在参与者域存在高偏倚风险;作者强烈推荐任何影像组学研究至少应进行内部验证。

要点

  • 一阶熵与胰腺导管腺癌总生存期显著相关(HR 1.66,95%CI 1.18-2.34)。
  • 仅5项研究进行内部验证、2项进行外部验证,验证普遍不足。
  • 22项研究因回顾性设计在参与者域存在高偏倚风险。

核心结论

  • 一阶熵与总生存期显著相关,可能提高胰腺导管腺癌预后预测的准确性。
  • 现有研究验证不足,未来研究应予以注意。
  • 由于影像组学与大数据的密切关系,PROBAST对前瞻性研究设计的严格要求可能不适用于影像组学研究,模型构建阶段需在研究类型与样本量之间找到平衡。

研究设计与样本

  • 系统评价纳入关于胰腺导管腺癌总生存期预测的影像组学文献,最终识别23项研究。
  • 对一阶熵的效应量进行Meta分析,纳入9项研究。
  • 采用影像组学质量评分(RQS)和预测模型偏倚风险评估工具(PROBAST)评估纳入研究的方法学质量和偏倚风险。

诊断标准与关键数值

  • 2项(8.7%)研究通过C-index比较影像组学模型与TNM分期模型的预后预测能力,均显示影像组学表现更好。
  • 21项(91.3%)研究报告影像组学特征具有显著预测价值。
  • Meta分析显示一阶熵与总生存期显著相关(HR 1.66,95%CI 1.18-2.34)。
  • RQS评估显示仅5项(21.7%)研究在内部数据集上进行验证,2项(8.7%)研究在外部数据集上进行验证。
  • PROBAST显示22项(95.7%)研究因回顾性研究设计在参与者域存在高偏倚风险。

临床应用与阅片要点

  • 作者强烈推荐任何影像组学研究至少应进行内部验证。
  • 应注意影像组学特征之间的复杂关系。
  • 由于影像组学与大数据的密切关系,PROBAST对前瞻性研究设计的严格要求可能不适用于影像组学研究,模型构建阶段需在研究类型与样本量之间找到平衡。

局限性

  • 验证仅在5项(21.7%)研究的内部数据集和2项(8.7%)研究的外部数据集上进行。
  • 22项(95.7%)研究因回顾性研究设计在参与者域存在高偏倚风险。
  • 现有研究验证不足,未来研究应予以注意。
  • PROBAST对前瞻性研究设计的严格要求可能不适用于影像组学研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We aimed to systematically evaluate the prognostic prediction accuracy of radiomics features extracted from pre-treatment imaging in patients with pancreatic ductal adenocarcinoma (PDAC).

METHODS: Radiomics literature on overall survival (OS) prediction of PDAC were all included in this systematic review. A further meta-analysis was performed on the effect size of first-order entropy. Methodological quality and risk of bias of the included studies were assessed by the radiomics quality score (RQS) and prediction model risk of bias assessment tool (PROBAST).

RESULTS: Twenty-three studies were finally identified in this review. Two (8.7%) studies compared prognosis prediction ability between radiomics model and TNM staging model by C-index, and both showed a better performance of the radiomics. Twenty-one (91.3%) studies reported significant predictive values of radiomics features. Nine (39.1%) studies were included in the meta-analysis, and it showed a significant correlation between first-order entropy and OS (HR 1.66, 95%CI 1.18-2.34). RQS assessment revealed validation was only performed in 5 (21.7%) studies on internal datasets and 2 (8.7%) studies on external datasets. PROBAST showed that 22 (95.7%) studies have a high risk of bias in participants because of the retrospective study design.

CONCLUSION: First-order entropy was significantly associated with OS and might improve the accuracy of PDAC prognosis prediction. Existing studies were poorly validated, and it should be noted in future studies. Modification of PROBAST for radiomics studies is necessary since the strict requirements of prospective study design may not be applicable to the demand for a large sample size in the model construction stage.

KEY POINTS: • Radiomics based on the primary lesion holds great potential for prognosis prediction. First-order entropy was significantly associated with the overall survival of PDAC and might improve the accuracy of current PDAC prognosis prediction. • We strongly recommend that at least an internal validation should be conducted in any radiomics study. Attention should be paid to the complex relationships between radiomics features. • Due to the close relationship between radiomics and big data, the strict requirement of prospective study design in PROABST may not be appropriate for radiomics studies. A balance between study types and sample sizes for radiomics studies needs to be found in the model construction stage.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Gao Y, Cheng S, Zhu L, et al. A systematic review of prognosis predictive role of radiomics in pancreatic cancer: heterogeneity markers or statistical tricks? Eur Radiol. 2022. PMID: 35904618. doi:10.1007/s00330-022-08922-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。